Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Fear of Public Speaking
NCT02790736Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of propranolol in Social Anxiety Disorder (SAD), sponsored by New York State Psychiatric Institute. Primary endpoint: Personal Report of Confidence as a Speaker at 2 weeks. Started Jun 2016; status: terminated.
02
Drugs
propranolol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT02790736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790736.